United States Androgen Deprivation Therapy (ADT) Market Research Report Forecast 2017-2022

July 2017 | 104 pages | ID: U4789E2C00CEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Androgen Deprivation Therapy (ADT) Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Androgen Deprivation Therapy (ADT) industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Androgen Deprivation Therapy (ADT) market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

United States Androgen Deprivation Therapy (ADT) Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Androgen Deprivation Therapy (ADT) Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 ANDROGEN DEPRIVATION THERAPY (ADT) MARKET OVERVIEW

1.1 Product Overview and Scope of Androgen Deprivation Therapy (ADT)
1.2 Androgen Deprivation Therapy (ADT) Market Segmentation by Type
  1.2.1 United States Production Market Share of Androgen Deprivation Therapy (ADT) by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Androgen Deprivation Therapy (ADT) Market Segmentation by Application
  1.3.1 Androgen Deprivation Therapy (ADT) Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Androgen Deprivation Therapy (ADT) (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON ANDROGEN DEPRIVATION THERAPY (ADT) INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES ANDROGEN DEPRIVATION THERAPY (ADT) MARKET COMPETITION BY MANUFACTURERS

3.1 United States Androgen Deprivation Therapy (ADT) Production and Share by Manufacturers (2015 and 2016)
3.2 United States Androgen Deprivation Therapy (ADT) Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Androgen Deprivation Therapy (ADT) Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Androgen Deprivation Therapy (ADT) Manufacturing Base Distribution, Production Area and Product Type
3.5 Androgen Deprivation Therapy (ADT) Market Competitive Situation and Trends
  3.5.1 Androgen Deprivation Therapy (ADT) Market Concentration Rate
  3.5.2 Androgen Deprivation Therapy (ADT) Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES ANDROGEN DEPRIVATION THERAPY (ADT) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Androgen Deprivation Therapy (ADT) Production and Market Share by Type (2012-2017)
4.2 United States Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2012-2017)
4.3 United States Androgen Deprivation Therapy (ADT) Price by Type (2012-2017)
4.4 United States Androgen Deprivation Therapy (ADT) Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ANALYSIS BY APPLICATION

5.1 United States Androgen Deprivation Therapy (ADT) Consumption and Market Share by Application (2012-2017)
5.2 United States Androgen Deprivation Therapy (ADT) Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURERS ANALYSIS

6.1 Pfizer Inc. (USA)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Abbott Laboratories (USA)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Genentech Inc. (USA)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 GlaxoSmithKline Plc (UK)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Immunomedics, Inc. (USA)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Indevus Pharmaceuticals Inc. (USA)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Novartis AG (Switzerland)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 OSI Pharmaceuticals, Inc. (USA)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Paladin Labs Inc. (Canada)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURING COST ANALYSIS

7.1 Androgen Deprivation Therapy (ADT) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES ANDROGEN DEPRIVATION THERAPY (ADT) MARKET FORECAST (2017-2022)

11.1 United States Androgen Deprivation Therapy (ADT) Production, Revenue Forecast (2017-2022)
11.2 United States Androgen Deprivation Therapy (ADT) Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Androgen Deprivation Therapy (ADT) Production Forecast by Type (2017-2022)
11.4 United States Androgen Deprivation Therapy (ADT) Consumption Forecast by Application (2017-2022)
11.5 Androgen Deprivation Therapy (ADT) Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Androgen Deprivation Therapy (ADT)
Table Classification of Androgen Deprivation Therapy (ADT)
Figure United States Sales Market Share of Androgen Deprivation Therapy (ADT) by Type in 2016
Table Application of Androgen Deprivation Therapy (ADT)
Figure United States Sales Market Share of Androgen Deprivation Therapy (ADT) by Application in 2016
Figure United States Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2021)
Figure United States Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)
Table United States Androgen Deprivation Therapy (ADT) Sales of Key Manufacturers (2015 and 2016)
Table United States Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers
Figure 2016 Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers
Table United States Androgen Deprivation Therapy (ADT) Revenue by Manufacturers (2015 and 2016)
Table United States Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table 2016 United States Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table United States Market Androgen Deprivation Therapy (ADT) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Androgen Deprivation Therapy (ADT) Average Price of Key Manufacturers in 2015
Figure Androgen Deprivation Therapy (ADT) Market Share of Top 3 Manufacturers
Figure Androgen Deprivation Therapy (ADT) Market Share of Top 5 Manufacturers
Table United States Androgen Deprivation Therapy (ADT) Sales by Type (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Sales Share by Type (2012-2017)
Figure United States Androgen Deprivation Therapy (ADT) Sales Market Share by Type in 2015
Table United States Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Androgen Deprivation Therapy (ADT) by Type (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Price by Type (2012-2017)
Figure United States Androgen Deprivation Therapy (ADT) Sales Growth Rate by Type (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Sales by Application (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2012-2017)
Figure United States Androgen Deprivation Therapy (ADT) Sales Market Share by Application in 2016
Table United States Androgen Deprivation Therapy (ADT) Sales Growth Rate by Application (2012-2017)
Figure United States Androgen Deprivation Therapy (ADT) Sales Growth Rate by Application (2012-2017)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2012-2017)
Table Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Androgen Deprivation Therapy (ADT)
Figure Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)
Figure Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
Table Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2016
Table Major Buyers of Androgen Deprivation Therapy (ADT)
Table Distributors/Traders List
Figure United States Androgen Deprivation Therapy (ADT) Production and Growth Rate Forecast (2017-2022)
Figure United States Androgen Deprivation Therapy (ADT) Revenue and Growth Rate Forecast (2017-2022)
Table United States Androgen Deprivation Therapy (ADT) Production Forecast by Type (2017-2022)
Table United States Androgen Deprivation Therapy (ADT) Consumption Forecast by Application (2017-2022)